Singapore Institute Advances Strategic Partnership with EnGeneIC

Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.

Don't Miss our Black Friday Offers:

Singapore Institute of Advanced Medicine Holdings Ltd. has announced a strategic partnership with EnGeneIC Pty Limited, focusing on the development of EDV-based products and theranostics. The collaboration has led to promising advancements in EnGeneIC’s proprietary technology, prompting an extension of the negotiation period for a definitive agreement. Shareholders will be informed of any significant updates as the partnership progresses.

For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.